Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice

被引:62
作者
De Sarro, G
De Sarro, A
Di Paola, ED
Bertorelli, R
机构
[1] Univ Catanzaro, Sch Med, Dept Exp & Clin Med, I-88100 Catanzaro, Italy
[2] Univ Messina, Sch Med, Inst Pharmacol, Messina, Italy
[3] Schering Plough Res Inst, I-20132 Milan, Italy
关键词
epilepsy; adenosine; adenosine receptor subtype; adenosine receptor agonist; adenosine receptor antagonist; seizure audiogenic; DBA/2; mice;
D O I
10.1016/S0014-2999(99)00132-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have studied the effects of selective and non-selective adenosine receptor agonists and antagonists in audiopenic-seizure-sensitive DBA/2 mice, an animal model of generalized reflex epilepsy. With the exception of the adenosine A(3) receptor agonist, N-6-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine (IB-MECA), all the agonists studied prevented the development of audiogenic seizures in a dose-dependent manner. The ED50 values against the clonic phase of the audiogenic seizures were low, that is: 0.06 mg/kg, i.p., for the adenosine A(1) receptor agonist, 2-chloro-N-6-cyclopentyladenosine (CCPA), 0.02 and 0.03 mg/kg, i.p., for the adenosine A(2A) receptor agonists, 2-(4-(2-carboxyethyl)-phenylamino)-5'-N-ethylcarboxamidoadenosine (CGS 21680) and 2-hexynyl-5'-N-ethyl-carboxamidoadenosine (2-HE-NECA), and 0.7 mg/kg, i.p., for the adenosine A(1)/A(3) receptor agonist, N-6-2-(4-aminophenyl)ethyladenosine (APNEA). Conversely, the non-selective agonist, N-ethyl-carboxamidoadenosine (NECA), was highly potent, the ED50 being 0.0005 mg/kg, i.p. In the absence of auditory stimulation, the adenosine receptor antagonists increased the incidence of both clonic and tonic seizures in DBA/2 mice. The ED50 values were: for caffeine, 207.5 mg/kg, i.p., for the adenosine A(1) receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), 327.8 mg/kg i.p., for the adenosine A(2A) receptor antagonists, 3,7-dimethyl-1-propylxanthine (DPMX), 86.7 mg/kg i.p., for the (E,18%-Z,82%)7-methyl-8-(3,4-dimethoxystyryl)-1,3-dipropylxanthine (KF 17837), 69.1 mg/kg i.p., and 5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo-(4,3-c)1,2,4-triaxzolo(1,5-c)-pyrimidine (SCH 58261), 321.8 mg/kg i.p. The rank order of convulsant potency in our epileptic model, following intracerebroventricular administration, was DPCPX > DMPX > 1,3,7-trimethyl-8-(3-chlorostyryl)xanthine (CSC)> KF 17837 > Caffeine > SCH 58261 > 5-amino-9-chloro-2-(2-furyl)-1,2,4-triazolo(1,5-c)quinazoline (CGS 15943). Following a subconvulsant audiogenic stimulus of 83 dB, all adenosine receptor antagonists induced both tonic and clonic seizures. The ED50 values for such proconvulsant effects were: for caffeine 0.04 mg/kg, i.p., for the adenosine A(1) receptor antagonist, DPCPX, 5.84 mg/kg, i.p., for the adenosine A(2A) receptor antagonists, DMPX, 0.02 mg/kg, i.p., CGS 15943, 0.29 mg/kg i.p., KF 17837, 0.57 mg/kg, i.p., CSC 0.12 mg/kg, i.p. and SCH 58261 0.07 mg/kg, i.p., respectively. These data suggest that stimulation of adenosine A(1) and A(2A) receptors is involved in the suppression of seizures. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 66 条
[1]   Effects of repeated administration of selective adenosine A(1) and A(2A) receptor agonists on pentylenetetrazole-induced convulsions in the rat [J].
Adami, M ;
Bertorelli, R ;
Ferri, N ;
Foddi, MC ;
Ongini, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 294 (2-3) :383-389
[2]   AMINOPHYLLINE AND KINDLED SEIZURES [J].
ALBERTSON, TE ;
STARK, LG ;
JOY, RM ;
BOWYER, JF .
EXPERIMENTAL NEUROLOGY, 1983, 81 (03) :703-713
[3]   ADENOSINE INHIBITS EPILEPTIFORM ACTIVITY ARISING IN HIPPOCAMPAL AREA CA3 [J].
AULT, B ;
WANG, CM .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 87 (04) :695-703
[4]   SYNTHESIS OF NEW PYRAZOLO[4,3-E]1,2,4-TRIAZOLO[1,5-C] PYRIMIDINE AND 1,2,3-TRIAZOLO[4,5-E]1,2,4-TRIAZOLO[1,5-C] PYRIMIDINE DISPLAYING POTENT AND SELECTIVE ACTIVITY AS A(2A) ADENOSINE RECEPTOR ANTAGONISTS [J].
BARALDI, PG ;
MANFREDINI, S ;
SIMONI, D ;
ZAPPATERRA, L ;
ZOCCHI, C ;
DIONISOTTI, S ;
ONGINI, E .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (21) :2539-2544
[5]  
Bertorelli R, 1996, DRUG DEVELOP RES, V37, P65, DOI 10.1002/(SICI)1098-2299(199602)37:2<65::AID-DDR1>3.0.CO
[6]  
2-J
[7]   N-6-2-(4-aminophenyl)ethyl-adenosine enhances the anticonvulsive activity of antiepileptic drugs [J].
Borowicz, KK ;
Kleinrok, Z ;
Czuczwar, SJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 327 (2-3) :125-133
[8]   ADENOSINE-ANALOGS - THE TEMPERATURE-DEPENDENCE OF THE ANTICONVULSANT EFFECT AND INHIBITION OF D-ASPARTATE-H-3 RELEASE [J].
BOWKER, HM ;
CHAPMAN, AG .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (17) :2949-2953
[9]  
CHAPMAN AG, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1261
[10]   BIDIRECTIONAL EFFECTS OF BETA-CARBOLINES IN REFLEX EPILEPSY [J].
CHAPMAN, AG ;
DESARRO, GB ;
PREMACHANDRA, M ;
MELDRUM, BS .
BRAIN RESEARCH BULLETIN, 1987, 19 (03) :337-346